Next Article in Journal
Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival
Previous Article in Journal
Impact of Endocrine Therapy for Cancer on Periodontal Health: A Systematic Review
 
 
Review

Article Versions Notes

Cancers 2025, 17(18), 3068; https://doi.org/10.3390/cancers17183068
Action Date Notes Link
article xml file uploaded 19 September 2025 13:56 CEST Original file -
article xml uploaded. 19 September 2025 13:56 CEST Update -
article pdf uploaded. 19 September 2025 13:56 CEST Version of Record https://www.mdpi.com/2072-6694/17/18/3068/pdf-vor
article html file updated 19 September 2025 13:57 CEST Original file -
article xml file uploaded 22 September 2025 06:11 CEST Update -
article xml uploaded. 22 September 2025 06:11 CEST Update https://www.mdpi.com/2072-6694/17/18/3068/xml
article pdf uploaded. 22 September 2025 06:11 CEST Updated version of record https://www.mdpi.com/2072-6694/17/18/3068/pdf
article html file updated 22 September 2025 06:12 CEST Update https://www.mdpi.com/2072-6694/17/18/3068/html
Back to TopTop